Please wait a minute...
Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology)  2006, Vol. 7 Issue (5 ): 1-    DOI: 10.1631/jzus.2006.B0331
    
Organ preconditioning: the past, current status, and related lung studies
Luh Shi-ping, Yang Pan-chyr
Department of Cardiothoracic Surgery, Taipei Tzu-Chi Medical University Hospital, Taiwan 231, China; Department of Medicine, National Taiwan University Hospital, Taipei, Taiwan 100, China
Download:     PDF (0 KB)     
Export: BibTeX | EndNote (RIS)      

Abstract  Preconditioning (PC) has emerged as a powerful method for experimentally and clinically attenuating various types of organ injuries. In this paper related clinical and basic research issues on organ preconditioning issues were systemically reviewed. Since lung injuries, including ischemia-reperfusion and others, play important roles in many clinical results, including thromboembolism, trauma, thermal injury, hypovolemic and endotoxin shock, reimplantation response after organ transplantation, and many respiratory diseases in critical care. It is of interest to uncover methods, including the PCs, to protect the lung from the above injuries. However, related studies on pulmonary PC are relatively rare and still being developed, so we will review previous literature on experimental and clinical studies on pulmonary PC in the following paragraphs.

Key wordsPreconditioning      Ischemia-reperfusion      Lung     
Received: 08 February 2006     
CLC:  R655  
Cite this article:

Luh Shi-ping, Yang Pan-chyr. Organ preconditioning: the past, current status, and related lung studies. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2006, 7(5 ): 1-.

URL:

http://www.zjujournals.com/xueshu/zjus-b/10.1631/jzus.2006.B0331     OR     http://www.zjujournals.com/xueshu/zjus-b/Y2006/V7/I5 /1

[1] Bo-yu Dong, Cheng Wang, Li Tan, Ning Tan, Meng-di Zhao, Yang Lu, Shou-ying Du. Inhibitory effect of Shenqi Fuzheng injection combined with docetaxel on lung cancer cells[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2017, 18(1): 76-78.
[2] Xi-ming Li, Feng Li, Zhong-kai Liu, Ming-tao Shao. Erratum to: Investigation of one-lung ventilation postoperative cognitive dysfunction and regional cerebral oxygen saturation relations[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2016, 17(7): 568-568.
[3] Zeng-hui Cheng, Yu-xin Shi, Min Yuan, Dan Xiong, Jiang-hua Zheng, Zhi-yong Zhang. Chemokines and their receptors in lung cancer progression and metastasis[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2016, 17(5): 342-351.
[4] Xi-ming Li, Feng Li, Zhong-kai Liu, Ming-tao Shao. Investigation of one-lung ventilation postoperative cognitive dysfunction and regional cerebral oxygen saturation relations[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2015, 16(12): 1042-1048.
[5] Sheng-hong Zhu, Li-jia Zhou, Hong Jiang, Rong-jun Chen, Chuan Lin, Shi Feng, Juan Jin, Jiang-hua Chen, Jian-yong Wu. Protective effect of indomethacin in renal ischemia-reperfusion injury in mice[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(8): 735-742.
[6] Yu Zhao, Chong-wei Zhang, Wen-jing Zhou, Jiao Chen, Nan-fu Luo, Li-na Gong, Lei Du, Jing Zhou. Is there a role of TNFR1 in acute lung injury cases associated with extracorporeal circulation?[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(3): 281-288.
[7] Duriya Fongmoon, Surathat Pongnikorn, Aphiruk Chaisena, Sitthichai Iamsaard. Particulate matters collected from ceramic factories in Lampang Province affecting rat lungs[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(1): 75-83.
[8] Pan Xu, Ying Li, Shou-ying Du, Yang Lu, Jie Bai, Qing-li Guo. Comparative pharmacokinetics of borneol in cerebral ischemia-reperfusion and sham-operated rats[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(1): 84-91.
[9] Guo-dong Xu, Xin-bao Shi, Le-bo Sun, Qing-yun Zhou, Da-wei Zheng, Huo-shun Shi, Yong-liang Che, Zi-shan Wang, Guo-feng Shao. Down-regulation of eIF5A-2 prevents epithelial-mesenchymal transition in non-small-cell lung cancer cells[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2013, 14(6): 460-467.
[10] Jie Cui, Zhi Li, Ling-bo Qian, Qin Gao, Jue Wang, Meng Xue, Xiao-e Lou, Iain C. Bruce, Qiang Xia, Hui-ping Wang. Reducing the oxidative stress mediates the cardioprotection of bicyclol against ischemia-reperfusion injury in rats[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2013, 14(6): 487-495.
[11] Wei Hong, Kai Wang, Yi-ping Zhang, Jun-yan Kou, Dan Hong, Dan Su, Wei-min Mao, Xin-min Yu, Fa-jun Xie, Xiao-jian Wang. Methylenetetrahydrofolate reductase C677T polymorphism predicts response and time to progression to gemcitabine-based chemotherapy for advanced non-small cell lung cancer in a Chinese Han population[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2013, 14(3): 207-215.
[12] Xian-bao Liu, Han Chen, Hui-qiang Chen, Mei-fei Zhu, Xin-yang Hu, Ya-ping Wang, Zhi Jiang, Yin-chuan Xu, Mei-xiang Xiang, Jian-an Wang. Angiopoietin-1 preconditioning enhances survival and functional recovery of mesenchymal stem cell transplantation[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2012, 13(8): 616-623.
[13] Li Yang, Min Lin, Wen-jing Ruan, Liang-liang Dong, En-guo Chen, Xiao-hong Wu, Ke-jing Ying. Nkx2-1: a novel tumor biomarker of lung cancer[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2012, 13(11): 855-866.
[14] Jian Chen, Qing-wei Zhao, Gen-ming Shi, Lin-run Wang. XRCC1 Arg399Gln and clinical outcome of platinum-based treatment for advanced non-small cell lung cancer: a meta-analysis in 17 studies[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2012, 13(11): 875-883.
[15] Lin-run Wang, Guo-bing Zhang, Jian Chen, Jun Li, Ming-wei Li, Nong Xu, Yang Wang, Jian-zhong Shentu. RRM1 gene expression in peripheral blood is predictive of shorter survival in Chinese patients with advanced non-small-cell lung cancer treated by gemcitabine and platinum[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2011, 12(3): 174-179.